Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6335)
All Articles published online
|
Publishing Process of This Article
|
May 26, 2014 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Cardiology
ISSN
1949-8462
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Vuilleumier N, Montecucco F, Hartley O. Autoantibodies to apolipoprotein A-1 as a biomarker of cardiovascular autoimmunity. World J Cardiol 2014; 6(5): 314-326 [PMID: 24944761 DOI: 10.4330/wjc.v6.i5.314] |
|---|---|
| URL: | https://www.wjgnet.com/1949-8462/full/v6/i5/314.htm |
| Number | Citing Articles |
| 1 |
Fabrizio Montecucco, Elda Favari, Giuseppe Danilo Norata, Nicoletta Ronda, Jerzy-Roch Nofer, Nicolas Vuilleumier. High Density Lipoproteins. Handbook of Experimental Pharmacology 2015; 224: 455 doi: 10.1007/978-3-319-09665-0_14
|
| 2 |
Nathalie Satta, Sabrina Pagano, Fabrizio Montecucco, Baris Gencer, François Mach, Laurent Kaiser, Alexandra Calmy, Nicolas Vuilleumier, V. Aubert, J. Barth, M. Battegay, E. Bernasconi, J. Böni, H.C. Bucher, C. Burton-Jeangros, A. Calmy, M. Cavassini, M. Egger, L. Elzi, J. Fehr, J. Fellay, P. Francioli, H. Furrer, C.A. Fux, M. Gorgievski, H. Günthard, D. Haerry, B. Hasse, H.H. Hirsch, B. Hirschel, I. Hösli, C. Kahlert, L. Kaiser, O. Keiser, C. Kind, T. Klimkait, H. Kovari, B. Ledergerber, G. Martinetti, B. Martinez de Tejada, K. Metzner, N. Müller, D. Nadal, G. Pantaleo, A. Rauch, S. Regenass, M. Rickenbach, C. Rudin, P. Schmid, D. Schultze, F. Schöni-Affolter, J. Schüpbach, R. Speck, P. Taffé, P. Tarr, A. Telenti, A. Trkola, P. Vernazza, R. Weber, S. Yerly. Anti-apolipoprotein A-1 autoantibodies are associated with immunodeficiency and systemic inflammation in HIV patients. Journal of Infection 2018; 76(2): 186 doi: 10.1016/j.jinf.2017.11.008
|
| 3 |
Dalia El-Lebedy, Enas Rasheed, Mona Kafoury, Dalia Abd-El Haleem, Eman Awadallah, Ingy Ashmawy. Anti-apolipoprotein A-1 autoantibodies as risk biomarker for cardiovascular diseases in type 2 diabetes mellitus. Journal of Diabetes and its Complications 2016; 30(4): 580 doi: 10.1016/j.jdiacomp.2016.02.014
|
| 4 |
Robin P. F. Dullaart, Sabrina Pagano, Frank G. Perton, Nicolas Vuilleumier. Antibodies Against the C-Terminus of ApoA-1 Are Inversely Associated with Cholesterol Efflux Capacity and HDL Metabolism in Subjects with and without Type 2 Diabetes Mellitus. International Journal of Molecular Sciences 2019; 20(3): 732 doi: 10.3390/ijms20030732
|
| 5 |
Aishwarya Sudam Bhale, Krishnan Venkataraman. Leveraging knowledge of HDLs major protein ApoA1: Structure, function, mutations, and potential therapeutics. Biomedicine & Pharmacotherapy 2022; 154: 113634 doi: 10.1016/j.biopha.2022.113634
|
| 6 |
А. Yu. Sidorov, K. V. Fomina, L. V. Beduleva. HDL apoprotein immunization induces T cell-mediated venulitis and inflammation in aorta. Medical Immunology (Russia) 2023; 25(3): 637 doi: 10.15789/1563-0625-HAI-2699
|
| 7 |
Tiphaine Mannic, Nathalie Satta, Sabrina Pagano, Magaly Python, Julien Virzi, Fabrizio Montecucco, Miguel A. Frias, Richard W. James, Andres D. Maturana, Michel F. Rossier, Nicolas Vuilleumier. CD14 as a Mediator of the Mineralocorticoid Receptor–Dependent Anti-apolipoprotein A-1 IgG Chronotropic Effect on Cardiomyocytes. Endocrinology 2015; 156(12): 4707 doi: 10.1210/en.2015-1605
|
| 8 |
Diana Vassallo, Helen Alderson, Nicolas Vuilleumier, James Ritchie, Darren Green, Sabrina Pagano, Julien Virzi, Constantina Chrysochou, Philip A Kalra. Association of novel biomarkers with major clinical outcomes in a cohort of patients with atherosclerotic renovascular disease. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 2019; 56(4): 488 doi: 10.1177/0004563219850850
|
| 9 |
Federico Carbone, Nathalie Satta, Fabrizio Montecucco, Julien Virzi, Fabienne Burger, Aline Roth, Gloria Roversi, Carmine Tamborino, Ilaria Casetta, Silva Seraceni, Alessandro Trentini, Marina Padroni, Franco Dallegri, Patrice H. Lalive, François Mach, Enrico Fainardi, Nicolas Vuilleumier. Anti‐ApoA‐1 IgG serum levels predict worse poststroke outcomes. European Journal of Clinical Investigation 2016; 46(9): 805 doi: 10.1111/eci.12664
|
| 10 |
Maria Joao Paiva-Lopes, Joana R. Batuca, Sofia Gouveia, Marta Alves, Ana Luisa Papoila, José Delgado Alves. Antibodies towards high-density lipoprotein components in patients with psoriasis. Archives of Dermatological Research 2020; 312(2): 93 doi: 10.1007/s00403-019-01986-x
|
| 11 |
Julia Y. Wang, Wei Zhang, Victor B. Roehrl, Michael W. Roehrl, Michael H. Roehrl. An Autoantigen Atlas From Human Lung HFL1 Cells Offers Clues to Neurological and Diverse Autoimmune Manifestations of COVID-19. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.831849
|
| 12 |
Elizabeth D. Crane, Ali A. Al-Hashimi, Jack Chen, Edward G. Lynn, Kevin Doyoon Won, Šárka Lhoták, Magda Naeim, Khrystyna Platko, Paul Lebeau, Jae Hyun Byun, Bobby Shayegan, Joan C. Krepinsky, Katey J. Rayner, Serena Marchiò, Renata Pasqualini, Wadih Arap, Richard C. Austin. Anti-GRP78 autoantibodies induce endothelial cell activation and accelerate the development of atherosclerotic lesions. JCI Insight 2018; 3(24) doi: 10.1172/jci.insight.99363
|
| 13 |
Yin Zhang, Heru Zhao, Bin Liu, Li Li, Lulu Zhang, Mei Bao, Xinyu Ji, Xiaojuan He, Jianfeng Yi, Peng Chen, Cheng Lu, Aiping Lu. Low Level Antibodies Against Alpha-Tropomyosin Are Associated With Increased Risk of Coronary Heart Disease. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.00195
|
| 14 |
Dimitry A Chistiakov, Alexander N Orekhov, Yuri V Bobryshev. ApoA1 and ApoA1-specific self-antibodies in cardiovascular disease. Laboratory Investigation 2016; 96(7): 708 doi: 10.1038/labinvest.2016.56
|
| 15 |
Michael John Peck, Edward B. Sanders, Gerhard Scherer, Frank Lüdicke, Rolf Weitkunat. Review of biomarkers to assess the effects of switching from cigarettes to modified risk tobacco products. Biomarkers 2018; 23(3): 213 doi: 10.1080/1354750X.2017.1419284
|
| 16 |
I-Jung Tsai, Wen-Chi Shen, Jia-Zhen Wu, Yu-Sheng Chang, Ching-Yu Lin. Autoantibodies to Oxidatively Modified Peptide: Potential Clinical Application in Coronary Artery Disease. Diagnostics 2022; 12(10): 2269 doi: 10.3390/diagnostics12102269
|
| 17 |
Marie-Laure Santiago-Raber, Fabrizio Montecucco, Nicolas Vuilleumier, Kapka Miteva, Daniela Baptista, Federico Carbone, Sabrina Pagano, Aline Roth, Fabienne Burger, Francois Mach, Karim J. Brandt. Atherosclerotic plaque vulnerability is increased in mouse model of lupus. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-74579-8
|
| 18 |
Zhengda Pang, Akifumi Kushiyama, Jiao Sun, Takako Kikuchi, Hiroki Yamazaki, Yasuhiko Iwamoto, Hiroshi Koriyama, Shota Yoshida, Munehisa Shimamura, Masayoshi Higuchi, Tomohiro Kawano, Yoichi Takami, Hiromi Rakugi, Ryuichi Morishita, Hironori Nakagami. Glial fibrillary acidic protein (GFAP) is a novel biomarker for the prediction of autoimmune diabetes. The FASEB Journal 2017; 31(9): 4053 doi: 10.1096/fj.201700110R
|
| 19 |
Miguel A. Frias, Julien Virzi, Joana Batuca, Sabrina Pagano, Natahlie Satta, Jose Delgado Alves, Nicolas Vuilleumier. ELISA methods comparison for the detection of auto-antibodies against apolipoprotein A1. Journal of Immunological Methods 2019; 469: 33 doi: 10.1016/j.jim.2019.03.011
|
| 20 |
Priscila Camillo Teixeira, Philippe Ferber, Nicolas Vuilleumier, Paul Cutler. Biomarkers for cardiovascular risk assessment in autoimmune diseases. PROTEOMICS – Clinical Applications 2015; 9(1-2): 48 doi: 10.1002/prca.201400125
|
| 21 |
Simon H. Bridge, Sabrina Pagano, Meleri Jones, Graham R. Foster, Dermot Neely, Nicolas Vuilleumier, Margaret F. Bassendine. Autoantibody to apolipoprotein A-1 in hepatitis C virus infection: a role in atherosclerosis?. Hepatology International 2018; 12(1): 17 doi: 10.1007/s12072-018-9842-5
|
| 22 |
Astrid Malézieux-Picard, Leire Azurmendi, Sabrina Pagano, Nicolas Vuilleumier, Jean-Charles Sanchez, Dina Zekry, Jean-Luc Reny, Jérôme Stirnemann, Nicolas Garin, Virginie Prendki. Role of Clinical Characteristics and Biomarkers at Admission to Predict One-Year Mortality in Elderly Patients with Pneumonia. Journal of Clinical Medicine 2021; 11(1): 105 doi: 10.3390/jcm11010105
|